CSIMarket
 
Sonoma Pharmaceuticals Inc   (SNOA)
Other Ticker:  
 
 

Sonoma Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2024, Sonoma Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 2.82 in the third quarter 2023, otherwise the ratio remained above the average, as SNOA's markets remain strong.Sonoma Pharmaceuticals Inc 's average inventory processing period in the Dec 31 2023 quarter, has increased to 129 days, from 121 days, in the Sep 30 2023 quarter.

Within Healthcare sector 99 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2024, to 174, from total ranking in the second quarter 2024 at 860.

SNOA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sonoma Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?


SNOA Inventory Turnover Ratio (Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Inventory Growth 3.72 % -16.93 % -2.08 % 7.32 % -1.04 %
Y / Y Cost of Sales Growth -20.59 % -12.73 % -12.38 % -2.36 % 24.37 %
Inventory Turnover Ratio (TTM) 2.82 3.01 2.96 3.05 3.12
SNOA's Total Ranking # 174 # 860 # 849 # 1195 # 1115
Average inventory processing period 129 121 123 120 117
Seq. Inventory Growth 17.59 % -7.95 % -4.48 % 0.32 % -5.82 %
Seq. Cost of Sales Growth -3.62 % -21.68 % 3.4 % 1.75 % 5.91 %



Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 100
Overall Market # 174

Inventory Turnover Ratio Statistics
High Average Low
3.92 2.11 0.27
(Dec 31 2020)   (Dec 31 2017)




Financial Statements
Sonoma Pharmaceuticals Inc 's Inventories $ 3 Millions Visit SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Cost of Revenues TTM $ 8 Millions Visit SNOA's Income Statement
What are SNOA's Sales? Visit SNOA's Sales by Segment

Other Inventory Turnover Ratios
Sonoma Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SNOA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SNOA's Competitors
Inventory Turnover Ratio for SNOA's Suppliers
Inventory Turnover Ratio for SNOA's Customers

You may also want to know
SNOA's Sales Growth Rates SNOA's Pe Price to earnings ratio SNOA's Receivables Turnover Ratio SNOA's Stock Quote
SNOA's Net Income Growth Rates SNOA's Ps Price to Sales ratio SNOA's Sales per Employee SNOA's Asset Turnover Ratio
SNOA's Net Margin SNOA's Pb Price to Book ratio SNOA's Financial Strength Ratios SNOA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
Owens and Minor inc  7.06 $ 8,208.000  Millions$ 1,163  Millions
Kewaunee Scientific Corporation  6.88 $ 150.625  Millions$ 22  Millions
Hutchmed china Limited  6.61 $ 331.984  Millions$ 50  Millions
Cardiff Lexington Corporation  6.59 $ 3.561  Millions$ 1  Millions
Fonar Corporation  6.39 $ 17.389  Millions$ 3  Millions
Veracyte inc   6.25 $ 88.913  Millions$ 14  Millions
Star Equity Holdings Inc   6.12 $ 33.859  Millions$ 6  Millions
Patterson Companies Inc   5.96 $ 5,166.391  Millions$ 867  Millions
Avantor Inc   5.30 $ 4,603.400  Millions$ 868  Millions
Lifemd Inc   5.28 $ 18.000  Millions$ 3  Millions
Incyte Corporation  5.18 $ 254.990  Millions$ 49  Millions
Enzo Biochem Inc  5.13 $ 49.539  Millions$ 10  Millions
Abbvie inc   5.11 $ 20,415.000  Millions$ 3,992  Millions
Integer Holdings Corporation  5.09 $ 1,178.000  Millions$ 232  Millions
Exact Sciences Corporation  5.08 $ 654.248  Millions$ 129  Millions
Cytosorbents Corporation  4.99 $ 13.000  Millions$ 3  Millions
Warby Parker Inc   4.86 $ 304.000  Millions$ 63  Millions
Cryoport inc   4.84 $ 133.923  Millions$ 28  Millions
Twist Bioscience Corporation  4.84 $ 168.474  Millions$ 35  Millions
Henry Schein Inc  4.58 $ 8,478.000  Millions$ 1,852  Millions
Catalyst Pharmaceuticals Inc   4.54 $ 51.967  Millions$ 11  Millions
Vericel Corporation  4.51 $ 61.940  Millions$ 14  Millions
Ufp Technologies Inc   4.42 $ 287.000  Millions$ 65  Millions
Precision Optics Corporation Inc   4.41 $ 13.019  Millions$ 3  Millions
Catalent Inc   4.35 $ 3,363.000  Millions$ 773  Millions
Bristol myers Squibb Company  4.25 $ 10,693.000  Millions$ 2,517  Millions
Integrated Biopharma Inc  4.25 $ 45.487  Millions$ 11  Millions
Blueprint Medicines Corporation  4.20 $ 75.795  Millions$ 18  Millions
Escalon Medical Corp   4.16 $ 6.730  Millions$ 2  Millions
West Pharmaceutical Services Inc   4.13 $ 1,820.000  Millions$ 441  Millions

Date modified: 2024-02-08T22:26:02+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com